Pr Benjamin Besse
- Spécialité
- Oncologue médical, expert poumon
- Titre
- Directeur de la Recherche Clinique
- Hôpital
- Gustave Roussy (Villejuif)
- Derniers articles
-
- Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis. (11 sept. 2025)
- Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC. (7 sept. 2025)
- Expanded senescent CD8 T-cells in IMID patients are associated with distinct inflammatory cytokines. (6 sept. 2025)
- Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer. (2 sept. 2025)
- Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial. (1 sept. 2025)